These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17329207)

  • 21. KCNQ-Encoded Potassium Channels as Therapeutic Targets.
    Barrese V; Stott JB; Greenwood IA
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():625-648. PubMed ID: 28992433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels.
    Bentzen BH; Schmitt N; Calloe K; Dalby Brown W; Grunnet M; Olesen SP
    Neuropharmacology; 2006 Nov; 51(6):1068-77. PubMed ID: 16904708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and functional changes in a synthetic S5 segment of KvLQT1 channel as a result of a conserved amino acid substitution that occurs in LQT1 syndrome of human.
    Verma R; Ghosh JK
    Biochim Biophys Acta; 2010 Mar; 1798(3):461-70. PubMed ID: 20044973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs.
    Miceli F; Soldovieri MV; Martire M; Taglialatela M
    Curr Opin Pharmacol; 2008 Feb; 8(1):65-74. PubMed ID: 18061539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kv7.1 (KCNQ1) properties and channelopathies.
    Peroz D; Rodriguez N; Choveau F; Baró I; Mérot J; Loussouarn G
    J Physiol; 2008 Apr; 586(7):1785-9. PubMed ID: 18174212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome.
    Tian C; Vanoye CG; Kang C; Welch RC; Kim HJ; George AL; Sanders CR
    Biochemistry; 2007 Oct; 46(41):11459-72. PubMed ID: 17892302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation.
    Roura-Ferrer M; Solé L; Martínez-Mármol R; Villalonga N; Felipe A
    Biochem Biophys Res Commun; 2008 May; 369(4):1094-7. PubMed ID: 18331828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Kv7 channels in pain pathways.
    Rivera-Arconada I; Vicente-Baz J; Lopez-Garcia JA
    Oncotarget; 2017 Feb; 8(8):12554-12555. PubMed ID: 28199957
    [No Abstract]   [Full Text] [Related]  

  • 29. A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly.
    Schmitt N; Schwarz M; Peretz A; Abitbol I; Attali B; Pongs O
    EMBO J; 2000 Feb; 19(3):332-40. PubMed ID: 10654932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ca
    Tobelaim WS; Dvir M; Lebel G; Cui M; Buki T; Peretz A; Marom M; Haitin Y; Logothetis DE; Hirsch JA; Attali B
    Channels (Austin); 2017 Nov; 11(6):686-695. PubMed ID: 28976808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant Production, Reconstruction in Lipid-Protein Nanodiscs, and Electron Microscopy of Full-Length α-Subunit of Human Potassium Channel Kv7.1.
    Shenkarev ZO; Karlova MG; Kulbatskii DS; Kirpichnikov MP; Lyukmanova EN; Sokolova OS
    Biochemistry (Mosc); 2018 May; 83(5):562-573. PubMed ID: 29738690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.
    Moreno C; Oliveras A; de la Cruz A; Bartolucci C; Muñoz C; Salar E; Gimeno JR; Severi S; Comes N; Felipe A; González T; Lambiase P; Valenzuela C
    Cardiovasc Res; 2015 Sep; 107(4):613-23. PubMed ID: 26168993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
    Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
    Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of Kv7 (KCNQ) voltage-gated potassium channels by synthetic compounds.
    Xiong Q; Gao Z; Wang W; Li M
    Trends Pharmacol Sci; 2008 Feb; 29(2):99-107. PubMed ID: 18206251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kcnq1-5 (Kv7.1-5) potassium channel expression in the adult zebrafish.
    Wu C; Sharma K; Laster K; Hersi M; Torres C; Lukas TJ; Moore EJ
    BMC Physiol; 2014 Feb; 14():1. PubMed ID: 24555524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and subcellular localization of KCNQ1 with a heterozygous mutation in the C terminus.
    Yamashita F; Horie M; Kubota T; Yoshida H; Yumoto Y; Kobori A; Ninomiya T; Kono Y; Haruna T; Tsuji K; Washizuka T; Takano M; Otani H; Sasayama S; Aizawa Y
    J Mol Cell Cardiol; 2001 Feb; 33(2):197-207. PubMed ID: 11162126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.
    Li W; Du R; Wang QF; Tian L; Yang JG; Song ZF
    Biochem Biophys Res Commun; 2009 May; 383(2):206-9. PubMed ID: 19348785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second coiled-coil domain of KCNQ channel controls current expression and subfamily specific heteromultimerization by salt bridge networks.
    Nakajo K; Kubo Y
    J Physiol; 2008 Jun; 586(12):2827-40. PubMed ID: 18440995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
    Padilla K; Wickenden AD; Gerlach AC; McCormack K
    Neurosci Lett; 2009 Nov; 465(2):138-42. PubMed ID: 19733209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.